For example, inhibiting fatty acid transport protein 2 (FATP2) reduces the synthesis of immunosuppressive lipid mediators, thereby reversing the pro-tumor phenotype and delaying breast cancer progression (101). Here, SLC27A2 is linked to breast carcinoma.